Cargando…
Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects
Background: Recently, circulating microRNAs (miRNAs) from maternal blood and amniotic fluid have been used as biomarkers for ventricular septal defect (VSD) diagnosis. However, whether circulating miRNAs are associated with fetal myocardium remains unknown. Methods: Dimethadione (DMO) induced a VSD...
Autores principales: | Yang, Yiru, Yang, Hainan, Lian, Xihua, Yang, Shuping, Shen, Haolin, Wu, Shufen, Wang, Xiali, Lyu, Guorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403759/ https://www.ncbi.nlm.nih.gov/pubmed/36035156 http://dx.doi.org/10.3389/fgene.2022.899034 |
Ejemplares similares
-
The dimethadione-exposed rat fetus: an animal model for the prenatal ultrasound characterization of ventricular septal defect
por: Yang, Yiru, et al.
Publicado: (2023) -
Maternal body fluid lncRNAs serve as biomarkers to diagnose ventricular septal defect: from amniotic fluid to plasma
por: Wang, Huaming, et al.
Publicado: (2023) -
Maternal Circulating Exosomal miRNAs as Non-invasive Biomarkers for the Prediction of Fetal Ventricular Septal Defect
por: Jin, Yuxia, et al.
Publicado: (2021) -
Efficient Mining of Variants From Trios for Ventricular Septal Defect Association Study
por: Jiang, Peng, et al.
Publicado: (2019) -
Identification of Rare Copy Number Variants Associated With Pulmonary Atresia With Ventricular Septal Defect
por: Xie, Huilin, et al.
Publicado: (2019)